Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acerus Pharmaceuticals Corp (ASP.TO)

Acerus Pharmaceuticals Corp (ASP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acerus Pharmaceuticals Corp 7025 Langer Drive Suite 205 Mississauga ON L5N 0E8 CAN

https://www.aceruspharma.com P: 289-326-5789 F: 905-569-1809

Description:

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Key Statistics

Overview:

Market Capitalization, $K 2,775
Shares Outstanding, K 7,708
Annual Sales, $ -4,133 K
Annual Net Income, $ -33,817 K
Last Quarter Sales, $ 770 K
Last Quarter Net Income, $ -4,173 K
60-Month Beta 0.91
% of Institutional Shareholders 0.06%

Growth:

1-Year Return -94.86%
3-Year Return -97.75%
5-Year Return -99.38%

Per-Share Information:

Latest Earnings Date 03/13/23
Earnings Per Share ttm -3.24
Dividend Payout Ratio 0.00%
Most Recent Split 1-200 on 04/29/22

ASP.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -95.16%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales 0.67
Price/Book N/A
Book Value/Share -2.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar